Vevizye is a medicine for adults with moderate to severe dry eye disease (also known as keratoconjunctivitis sicca) which has not improved despite treatment with tear substitutes. Vevizye contains the active substance ciclosporin.
Therapeutic Indication
### Therapeutic indication Treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca) in adult patients, which has not improved despite treatment with tear substitutes.
Therapeutic Area (MeSH)
ATC Code
S01XA18
ATC Item
ciclosporin
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ciclosporin | N/A | 环孢素 |
EMA Name
Vevizye
Medicine Name
Vevizye
Aliases
N/ANo risk management plan link.
